The Dermatology Digest

MARCH 10, 2025

” The safety profile was consistent with the known safety profile of tildrakizumab, and no serious adverse events related to ILUMYA treatment occurred in this clinical trial,the study showed. . ” The post Tildrakizumab (Ilumya, Sun Pharma) Improves Moderate-to-severe Nail PsO appeared first on The Dermatology Digest.

Pharmaceutical 36

Pharmaceutical Safety Clinic Injections 36

The Dermatology Digest

NOVEMBER 30, 2024

Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Incyte is investigating the efficacy and safety of ruxolitinib cream in cutaneous lichen planus.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

The Dermatology Digest

MARCH 8, 2025

The Phase 3 TRuE-PN clinical trial program comprises TRuE-PN1 and TRuE-PN2 studies, which evaluate the safety and efficacy of twice-daily ruxolitinib cream 1.5% “PN is an intensely itchy skin disease, and for many years, there were no approved therapies, he says. The overall safety profile of ruxolitinib cream 1.5%

Safety 36

Safety Clinic Therapy Dermatology 36

The Dermatology Digest

NOVEMBER 6, 2024

” The TBA recipients include: Innovating Pain and Fatigue Management Cynthia Aranow, MD, The Feinstein Institutes for Medical Research Dr. Aranow will evaluate the use of a new, non-toxic, non-painful device that stimulates the vagus nerve to reduce pain and fatigue in people with SLE.

Hospital 36

Hospital Therapy Management Networking 36

Dermatology Times

APRIL 11, 2025

Panelists discuss how to identify suitable patients for JAK inhibitor therapy by evaluating disease severity, medical history, risk factors, and individual treatment goals while considering contraindications and safety considerations.

Therapy 36

Therapy Safety Medical Treatments 36

The Dermatology Digest

APRIL 7, 2024

The new ladder divides nonsteroidal medication classes into treatments for exacerbations and maintenance therapies in an escalating order based on their increasing potential for adverse effects. Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A.

Treatments 77

Treatments Dermatitis Therapy Medical 77

The Dermatology Digest

AUGUST 20, 2024

Food and Drug Administration (FDA) approved apremilast for the treatment of moderate to severe plaque psoriasis in children and adolescents ages 6 and older who weigh at least 20 kg (44 lb) and are candidates for phototherapy or systemic therapy. The adverse events were consistent with the known safety profile of Otezla in adult patients.

Safety 74

Safety Injections Therapy Treatments 74

US Dermatologt Partners

JUNE 1, 2024

In the ever-evolving landscape of psoriasis treatment, oral therapies continue to play a crucial role. These medications have been staples in psoriasis management, particularly in countries like Germany, where they are frequently prescribed for moderate to severe cases. and a PASI 90 response rate of 22.3%.

Therapy 41

Therapy Injections Safety Management 41

Lipgloss and Aftershave

NOVEMBER 1, 2024

Dr. Krystal Briglia, L+A Medical + Wellness Editor Dr. Krystal Briglia of Triada Integrative Medicine + Wellness is a board-certified nurse practitioner specializing in aesthetic dermatology, integrative medicine, and wellness. Dermatologic Therapy. Journal of Dermatologic Therapy Wu, D., Farris, P. Goldberg, D. Rigopoulos, D.,

Chemical Peels 52

Chemical Peels Hyperpigmentation Vitamin C Microneedling 52

The Dermatology Digest

MARCH 18, 2025

has completed enrollment in its Phase 3 clinical trial evaluating aminolevulinic acid hydrochloride (Ameluz) with photodynamic therapy (PDT) for the treatment of mild to moderate actinic keratoses (AKs) on the extremities, neck, and trunk. Biofrontera Inc.

Treatments 36

Treatments Dermatology Safety Therapy 36

The Dermatology Digest

JULY 24, 2024

We will prioritize quality, broaden choices for medical professionals, and provide superior experiences and accessibility to the consumers.” . “We are confident that Hugel’s established track record in South Korea, coupled with BENEV’s network, will resonate well with the U.S.

Dermatology 78

Dermatology Sales Marketing Safety 78

The Dermatology Digest

FEBRUARY 10, 2025

Rezpegaldesleukin is an investigational biologic therapy that targets the interleukin-2 receptor complex to stimulate proliferation of inhibitory immune cells known as regulatory T cells. “We are pleased that rezpegaldesleukin has been designated a Fast Track product,” says Jonathan Zalevsky, Ph.D.,

Dermatitis 36

Dermatitis Therapy Office Safety 36

New Age Spa Institute

NOVEMBER 20, 2024

Licenses like those for esthetics, cosmetology , and massage therapy give professionals the legal right to practice their craft and offer services to the public. Choosing Between Esthetics, Cosmetology & Massage Therapy One of the most common questions we hear is, “ What’s the difference between an esthetician and a cosmetologist?

Esthetics 52

Esthetics Therapy Continuing Education Continuous Education 52

US Dermatologt Partners

MARCH 27, 2024

Red light therapy is considered one of the newest and most innovative skin rejuvenation procedures available. Dermatology Partners in Cedar Park, Texas , “ Red light therapy is so new that the dermatologic community hasn’t even settled on one name for it. What is Red Light Therapy? According to Dr. Jean Charles of U.S.

Therapy 41

Therapy Treatments Dermatology Collagen 41

US Dermatologt Partners

JANUARY 13, 2025

Desai, During professional acne extractions, I carefully cleanse skin, prep the area with numbing medications, and remove acne lesions without causing unnecessary trauma to the surrounding tissue. They also use topical and/or injected numbing medications to make the procedure more comfortable.

Extractions 41

Extractions Scarring Pores Chemical Peels 41

The Dermatology Digest

FEBRUARY 11, 2024

This particular study did not address other safety concerns, such as all-cause mortality, infections, or cancer. Nonetheless, in this large cohort, treated for a median duration of 16 weeks, there was no detectable cardiovascular risk in those receiving oral JAK inhibitor therapy. Ireland PA, Jansson N, Spencer SKR.

Dermatology 74

Dermatology Safety Clinic Therapy 74

American Esthetician Organization

AUGUST 17, 2023

From topical creams to oral medications, finding the right solution for this chronic skin condition can feel like an endless battle. However, there’s a new contender in the field of rosacea treatments that’s gaining momentum – laser therapy. These treatments typically involve topical medications or oral antibiotics.

Rosacea 88

Rosacea Treatments Medical Management 88

The Dermatology Digest

DECEMBER 13, 2024

Food and Drug Administration (FDA) has approved nemolizumab (Nemluvio, Galderma) for the treatment of patients aged 12 and older with moderate to severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies.

Dermatitis 69

Dermatitis Safety Eczema Dermatology 69

The Dermatology Digest

OCTOBER 30, 2024

Ultimately, our aim is to improve public health outcomes and raise awareness about the critical importance of sun safety in our communities,” say Drs. Shiri Nawrocki received $10,000 for her study titled, “Development of Patient-centered education materials for Dermatologic Toxicities of Anticancer Therapies in a Diverse Patient Population.”

Sun Protection 36

Sun Protection Dermatology Safety Innovations 36

The Dermatology Digest

SEPTEMBER 20, 2024

Food and Drug Administration (FDA) has approved Alpha Tau Medical Ltd.’s s Investigational Device Exemption (IDE) application to initiate a multi-center study for the treatment of recurrent cutaneous Squamous Cell Carcinoma (cSCC) in immunocompromised patients using Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT). Dr. Robert B.

Office 74

Office Clinic Safety Medical 74

AAFE - American Academy of Facial Esthetics

APRIL 22, 2024

Unveiling the Differences: PRF vs. PRP Platelet-Rich Plasma (PRP): PRP therapy involves extracting a patient’s blood, processing it to isolate platelets, and then re-injecting the concentrated platelets into targeted areas of the face.

Injections 60

Injections Facials Collagen Therapy 60

The Dermatology Digest

JANUARY 21, 2024

What’s more, delgocitinib cream 20 mg/g was well-tolerated over 16 weeks, and no safety concerns were identified. Oral medications like alitretinoin are not available in all areas and not approved for use in the U.S so access to medications can be limiting. Study author Melinda J. The bottom line? Enter JAK inhibition.

Safety 36

Safety Eczema Social Media Dermatology 36

Aesthetics Advisor

JULY 4, 2024

In recent years, the allure of IV drip therapy has surged, captivating both health enthusiasts and celebrities alike. This intriguing medical innovation promises a plethora of health benefits, leaving many curious minds wondering: What magic lies within those IV bags, and is it truly transformative? What is IV drip therapy?

Therapy 36

Therapy Vitamin C Injections Medical 36

The Dermatology Digest

FEBRUARY 14, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

MARCH 12, 2024

in patients with HS met its primary endpoint, reinforcing the efficacy and safety profile of ruxolitinib cream 1.5%, demonstrating potential as a novel treatment option for people living with HS,” study author Martina J. Porter, MD, a dermatologist at Beth Israel Deaconess Medical Center in Boston, tells TDD.

Therapy 69

Therapy Safety Dermatology Treatments 69

AAAMS

AUGUST 4, 2023

It reduces disability, diminishes reliance on pain medications and heightens daily functioning, enabling patients to reclaim their lives from the grip of migraines. While some patients may be free of migraines through Botox alone, others may need additional treatments or therapies. Why Use Botox as a Treatment for Migraines?

Injections 52

Injections Surgery Medical Training 52

The Dermatology Digest

MAY 6, 2024

The Phase 2a trial ( NCT05984784 ) evaluates the safety, pharmacokinetics, and efficacy of IMG-007 in adult patients with moderate-to-severe AD who had inadequate response to and/or intolerant of topical therapies. Topical or systemic AD medications were not permitted during the study. and Canada. with IGA=4.

Safety 36

Safety Therapy Dermatitis Dermatology 36

AAAMS

AUGUST 4, 2023

It reduces disability, diminishes reliance on pain medications and heightens daily functioning, enabling patients to reclaim their lives from the grip of migraines. While some patients may be free of migraines through Botox alone, others may need additional treatments or therapies. Why Use Botox as a Treatment for Migraines?

Injections 52

Injections Surgery Medical Training 52

Spa Executive

JUNE 28, 2024

Wellness retreats continue to proliferate across the country, offering travelers opportunities to rejuvenate through practices like yoga, meditation, spa treatments and alternative therapies. These therapies are offered in dedicated sound therapy spaces within the spa or wellness facility, or even integrated into the hydrotherapy area.

Sustainability 52

Sustainability Therapy Technology Medical 52

AAAMS

MAY 9, 2024

However, with advancements in medical technology and people’s interest in cosmetic procedures, nurses started seeking additional aesthetic training. Nurses were first taught the importance of maintaining a clean and sterile environment, with safety being the top priority. Ethics and patient safety are non-negotiable.

Training 52

Training Technology Ethics Injections 52

The Dermatology Digest

MAY 23, 2024

Kimball, MD, MPH, Beth Israel Deaconess Medical Center and Professor of Dermatology, Harvard Medical School, Boston, MA. “In The safety profile of bimekizumab was consistent with safety data seen in previous trials with no new observed safety signals. The primary endpoint in both trials was HiSCR50 at Week 16.

Sustainability 36

Sustainability Safety Clinic Medical 36

The Dermatology Digest

SEPTEMBER 12, 2024

In the confirmatory phase 3 study (LIBERTY-CUPID Study C), dupilumab met the primary and key secondary endpoints for the investigational treatment of patients with uncontrolled, biologic-naïve CSU receiving background therapy with antihistamines. At 24 weeks, efficacy among patients receiving Dupixent compared to placebo was as follows: 8.64-point

Safety 36

Safety Office Medical Dermatology 36

AAAMS

APRIL 21, 2024

Body liposuction contouring has become a sought-after medical aesthetic procedure due to its ability to enhance one’s appearance and boost self-confidence. Selecting the right hands-on training is crucial for medical doctors, nurse practitioners, and physician assistants who aspire to excel in body liposuction and contouring.

Training 52

Training Technology Medical Safety 52

The Dermatology Digest

OCTOBER 21, 2024

Currently, the standard of care predominantly involves corticosteroids, topical therapies, traditional disease-modifying anti-rheumatic drugs (tDMARDs), and, in more severe or refractory cases, intravenous immunoglobulin (IVIg) or off-label biologics, underscoring the growing unmet need for novel therapeutic options to treat this condition.

Treatments 41

Treatments Injections Therapy Management 41

Northern Colorado Advanced Aesthetics Academy

JANUARY 27, 2022

An aesthetic laser technician is a skilled medical professional trained to provide laser services to patients. These individuals are responsible for providing accurate and consistent treatment to patients, taking great care that safety measures are in place during the treatments. What Is an Aesthetic Laser Technician?

Private Practice 36

Private Practice Training Safety Esthetics 36

The Dermatology Digest

JULY 10, 2024

The interleukin-13 blocker is indicated for the treatment of adult and adolescent patients (12 years and older with a body weight of at least 40 kg) with moderate to severe AD, who are candidates for systemic therapy. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

The Dermatology Digest

FEBRUARY 7, 2024

The total duration of the trial was up to 24 weeks, which included a four-week screening period, a 16-week treatment period and a four-week safety follow-up period. Improvements were also consistent across Patient Reported Outcomes through Week 16.

Safety 36

Safety Clinic Office Dermatology 36